Financial results - FARMACIA ELIGIAFARM SRL

Financial Summary - Farmacia Eligiafarm Srl
Unique identification code: 36691748
Registration number: J02/1342/2016
Nace: 4773
Sales - Ron
561.977
Net Profit - Ron
38.143
Employee
7
The most important financial indicators for the company Farmacia Eligiafarm Srl - Unique Identification Number 36691748: sales in 2023 was 561.977 euro, registering a net profit of 38.143 euro and having an average number of 7 employees. Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Farmacia Eligiafarm Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - 70.000 329.345 315.781 358.480 405.650 488.372 561.977
Total Income - EUR - - - 70.977 331.526 316.168 358.487 405.651 488.373 561.978
Total Expenses - EUR - - - 76.684 280.691 274.036 318.630 397.363 459.298 517.211
Gross Profit/Loss - EUR - - - -5.707 50.835 42.132 39.857 8.288 29.075 44.767
Net Profit/Loss - EUR - - - -6.417 47.512 38.970 35.973 4.173 24.502 38.143
Employees - - - 3 6 6 7 8 8 7
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 15.4%, from 488.372 euro in the year 2022, to 561.977 euro in 2023. The Net Profit increased by 13.715 euro, from 24.502 euro in 2022, to 38.143 in the last year.

Check the financial reports for the company - Farmacia Eligiafarm Srl

Rating financiar

Financial Rating -
Farmacia Eligiafarm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Farmacia Eligiafarm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Farmacia Eligiafarm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Farmacia Eligiafarm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Farmacia Eligiafarm Srl - CUI 36691748

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - 0 57 56 20.814 20.052 10.375 2.078
Current Assets - - - 65.786 212.721 282.733 240.445 239.883 254.694 230.711
Inventories - - - 62.830 155.814 182.615 174.149 158.644 140.125 160.428
Receivables - - - 2.172 40.023 63.907 51.761 45.929 60.729 61.056
Cash - - - 784 16.884 36.211 14.535 35.310 53.839 9.227
Shareholders Funds - - - -6.373 41.256 79.427 113.894 75.111 99.846 51.221
Social Capital - - - 44 43 42 41 40 41 40
Debts - - - 72.159 171.522 203.361 147.364 184.823 165.223 181.568
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 230.711 euro in 2023 which includes Inventories of 160.428 euro, Receivables of 61.056 euro and cash availability of 9.227 euro.
The company's Equity was valued at 51.221 euro, while total Liabilities amounted to 181.568 euro. Equity decreased by -48.322 euro, from 99.846 euro in 2022, to 51.221 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Farmacia Eligiafarm Srl

Comments - Farmacia Eligiafarm Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.